Skip to main content
Premium Trial:

Request an Annual Quote

Incogen Receives Remaining $1.2M NIH Funding for Cancer Dx Software Project

NEW YORK, April 4 (GenomeWeb News) - Incogen said last week that after meeting first-year milestones, it has received the $1.2 million remaining on a $2-million National Institutes of Health grant.

 

According to Incogen, the grant will help support its research into cancer diagnostics, and involves a collaboration with researchers from the College of William and from the EasternVirginiaMedicalSchool.

 

The NIH award is a Phase II follow-on to a previous grant received in 2003, Incogen said. That first grant provided funding for the development of a pilot project in the analysis of data obtained from surface-enhanced laser desorption ionization mass spectrometry.

 

The Phase II work is focused on developing a clinical diagnostic software package based on Incogen's Visual Integrated Bioinformatics Environment software.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.